Text Size
10 studies found for:    Alzheimer's | Open Studies | United States, Utah

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 200 mg/day;   Drug: Placebo
2 Recruiting Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: LY2886721;   Drug: Placebo
3 Recruiting Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BMS-241027;   Drug: Placebo matching BMS-241027
4 Recruiting Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
Conditions: Agitation;   Alzheimer's Disease
Interventions: Drug: AVP-923 (dextromethorphan/quinidine);   Drug: Placebo
5 Recruiting A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease
Conditions: Alzheimer Disease;   Healthy Volunteers
Interventions: Drug: LY2886721;   Drug: Placebo
6 Recruiting An Efficacy and Safety Trial of MK-8931 in Mild to Moderate Alzheimer's Disease (P07738 AM3)
Condition: Alzheimer's Disease
Interventions: Drug: MK-8931;   Drug: Placebo
7 Recruiting A Study of Gantenerumab in Patients With Prodromal Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: gantenerumab;   Drug: placebo
8 Recruiting Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Condition: Dementia
Intervention: Procedure: FDG-PET brain scan
9 Recruiting Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline
Condition: Alzheimer's Disease
Intervention: Drug: florbetapir (18F)
10 Recruiting Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Rasagiline;   Drug: Placebo
To Top

† Indicates status has not been verified in more than two years